Literature DB >> 24265907

The Berlin Declaration on tuberculosis and its consequences for TB research and control in the WHO-Euro region.

T Ulrichs1.   

Abstract

In his famous presentation 'Ueber Tuberculose', Robert Koch (1843-1910) changed the view on tuberculosis as disease, identified Mycobacterium tuberculosis as the etiologic agent and revolutionized the fight against infectious disease in diagnosis, therapy and prevention. Koch gave this presentation in Berlin on March 24, 1882 [1]. Exactly 100 years later, 1982, the International Union Against Tuberculosis and Lung Disease (IUATLD) proposed the 24th of March as 'World Tuberculosis Day'. Fourteen years later, in 1996, the World Health Organization (WHO) confirmed this day as the official day commemorating the disease and its victims, as well as the global endeavours to fight tuberculosis.

Entities:  

Keywords:  tuberculosis, World Tuberculosis Day, Berlin Declaration on Tuberculosis, Koch–Metschnikow-Forum

Year:  2012        PMID: 24265907      PMCID: PMC3832071          DOI: 10.1556/EuJMI.2.2012.4.3

Source DB:  PubMed          Journal:  Eur J Microbiol Immunol (Bp)        ISSN: 2062-509X


  10 in total

1.  [Berlin Declaration on Tuberculosis: High Level Follow-Up of High Priority Countries for TB Control in the WHO-EURO Region 'Double Trouble or Double Success? Bringing Together Diseases and Programs' - a symposium report].

Authors:  S Castell; B Hauer; D Manissero; T Ulrichs; R Zaleskis; R Loddenkemper
Journal:  Pneumologie       Date:  2010-06-08

2.  Robert Koch and the white death: from tuberculosis to tuberculin.

Authors:  Christoph Gradmann
Journal:  Microbes Infect       Date:  2005-08-08       Impact factor: 2.700

3.  125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic?

Authors:  G B Migliori; R Loddenkemper; F Blasi; M C Raviglione
Journal:  Eur Respir J       Date:  2007-03       Impact factor: 16.671

Review 4.  Scaling up interventions to achieve global tuberculosis control: progress and new developments.

Authors:  Mario Raviglione; Ben Marais; Katherine Floyd; Knut Lönnroth; Haileyesus Getahun; Giovanni B Migliori; Anthony D Harries; Paul Nunn; Christian Lienhardt; Steve Graham; Jeremiah Chakaya; Karin Weyer; Stewart Cole; Stefan H E Kaufmann; Alimuddin Zumla
Journal:  Lancet       Date:  2012-05-19       Impact factor: 79.321

Review 5.  Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.

Authors:  Ruth McNerney; Markus Maeurer; Ibrahim Abubakar; Ben Marais; Timothy D McHugh; Nathan Ford; Karin Weyer; Steve Lawn; Martin P Grobusch; Ziad Memish; S Bertel Squire; Giuseppe Pantaleo; Jeremiah Chakaya; Martina Casenghi; Giovanni-Batista Migliori; Peter Mwaba; Lynn Zijenah; Michael Hoelscher; Helen Cox; Soumya Swaminathan; Peter S Kim; Marco Schito; Alexandre Harari; Matthew Bates; Samana Schwank; Justin O'Grady; Michel Pletschette; Lucica Ditui; Rifat Atun; Alimuddin Zumla
Journal:  J Infect Dis       Date:  2012-04-10       Impact factor: 5.226

Review 6.  Global tuberculosis control: lessons learnt and future prospects.

Authors:  Christian Lienhardt; Philippe Glaziou; Mukund Uplekar; Knut Lönnroth; Haileyesus Getahun; Mario Raviglione
Journal:  Nat Rev Microbiol       Date:  2012-05-14       Impact factor: 60.633

Review 7.  [Immunology of tuberculosis and current status of vaccine development].

Authors:  T Ulrichs
Journal:  Pneumologie       Date:  2008-03

Review 8.  [Control of tuberculosis in Russia and other countries of the former Soviet Union].

Authors:  F M Marx; E I Skachkova; I M Son; A K Strelis; O I Urazova; H Hahn; A Krämer; T Ulrichs
Journal:  Pneumologie       Date:  2009-03-03

9.  Research questions and priorities for tuberculosis: a survey of published systematic reviews and meta-analyses.

Authors:  Ioana Nicolau; Daphne Ling; Lulu Tian; Christian Lienhardt; Madhukar Pai
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

Review 10.  Vaccines against tuberculosis: where are we and where do we need to go?

Authors:  Tom H M Ottenhoff; Stefan H E Kaufmann
Journal:  PLoS Pathog       Date:  2012-05-10       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.